Lilly Eyes Aesthetic Medicine as GLP-1 Weight Loss Reshapes Faces
Eli Lilly is exploring aesthetic medicine as GLP-1 patients face facial volume loss and laxity — but no products, trials, or timelines are confirmed yet.
Topic
Ozempic Face
Topic
Ozempic Face
Eli Lilly Eyes Aesthetic Medicine as GLP-1 Weight Loss Reshapes Patient Demand
Eli Lilly is exploring aesthetic medicine as GLP-1-driven weight loss creates visible facial and body changes, the Indianapolis B…
Survey Finds More GLP-1 Patients Seeking Cosmetic Dermatology Care
A new Dermatology Times survey report finds rising numbers of GLP-1 patients seeking cosmetic care, driven by facial volume loss…
Medscape Asks Whether GLP-1 Therapy Is Reshaping Aesthetic Dermatology
Medscape frames 'Ozempic face' as a question rather than a verdict. The headline invites scrutiny of an emerging aesthetic concer…